Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Lisa Daniel-Fischer; Marlies Antlanger; Daniel Cejka; Kathrin Eller; Philipp Gauckler; Balazs Odler; Michael Rudnicki; Marcus D Säemann; Alice Schmidt; Gere Sunder-Plassmann; Martin Wiesholzer; Martin Windpessl; Emanuel Zitt; Franz Koenig; Larry A Greenbaum; Andreas Kronbichler; Christoph Aufricht

doi:10.1016/j.ekir.2023.10.027

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D Säemann, Alice Schmidt, Gere Sunder-Plassmann, Martin Wiesholzer, Martin Windpessl, Emanuel Zitt, Franz Koenig, Larry A Greenbaum, Andreas Kronbichler, Christoph Aufricht^*

^*Corresponding author for this work

Division of Internal Medicine 1 (University Hospital St. Pölten)

Research output: Journal article (peer-reviewed) › Letter/short communication

1 Citation (Scopus)

Original language	English
Pages (from-to)	478-481
Number of pages	4
Journal	Kidney International Reports
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/j.ekir.2023.10.027
Publication status	Published - 02 Feb 2024

Keywords

FSGS
clopidogrel
drug repurposing
proteinuria

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.ekir.2023.10.027

Cite this

Daniel-Fischer, L., Antlanger, M., Cejka, D., Eller, K., Gauckler, P., Odler, B., Rudnicki, M., Säemann, M. D., Schmidt, A., Sunder-Plassmann, G., Wiesholzer, M., Windpessl, M., Zitt, E., Koenig, F., Greenbaum, L. A., Kronbichler, A., & Aufricht, C. (2024). Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design. Kidney International Reports, 9(2), 478-481. https://doi.org/10.1016/j.ekir.2023.10.027

@article{e273b5904b29418385b8f27118f91bfa,

title = "Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design",

keywords = "FSGS, clopidogrel, drug repurposing, proteinuria",

author = "Lisa Daniel-Fischer and Marlies Antlanger and Daniel Cejka and Kathrin Eller and Philipp Gauckler and Balazs Odler and Michael Rudnicki and S{\"a}emann, {Marcus D} and Alice Schmidt and Gere Sunder-Plassmann and Martin Wiesholzer and Martin Windpessl and Emanuel Zitt and Franz Koenig and Greenbaum, {Larry A} and Andreas Kronbichler and Christoph Aufricht",

year = "2024",

month = feb,

day = "2",

doi = "10.1016/j.ekir.2023.10.027",

language = "English",

volume = "9",

pages = "478--481",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

number = "2",

}

Daniel-Fischer, L, Antlanger, M, Cejka, D, Eller, K, Gauckler, P, Odler, B, Rudnicki, M, Säemann, MD, Schmidt, A, Sunder-Plassmann, G, Wiesholzer, M, Windpessl, M, Zitt, E, Koenig, F, Greenbaum, LA, Kronbichler, A & Aufricht, C 2024, 'Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design', Kidney International Reports, vol. 9, no. 2, pp. 478-481. https://doi.org/10.1016/j.ekir.2023.10.027

TY - JOUR

T1 - Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis

T2 - Phase 2 Trial Design

AU - Daniel-Fischer, Lisa

AU - Antlanger, Marlies

AU - Cejka, Daniel

AU - Eller, Kathrin

AU - Gauckler, Philipp

AU - Odler, Balazs

AU - Rudnicki, Michael

AU - Säemann, Marcus D

AU - Schmidt, Alice

AU - Sunder-Plassmann, Gere

AU - Wiesholzer, Martin

AU - Windpessl, Martin

AU - Zitt, Emanuel

AU - Koenig, Franz

AU - Greenbaum, Larry A

AU - Kronbichler, Andreas

AU - Aufricht, Christoph

PY - 2024/2/2

Y1 - 2024/2/2

KW - FSGS

KW - clopidogrel

KW - drug repurposing

KW - proteinuria

UR - http://www.scopus.com/inward/record.url?scp=85180340521&partnerID=8YFLogxK

U2 - 10.1016/j.ekir.2023.10.027

DO - 10.1016/j.ekir.2023.10.027

M3 - Letter/short communication

C2 - 38344717

SN - 2468-0249

VL - 9

SP - 478

EP - 481

JO - Kidney International Reports

JF - Kidney International Reports

IS - 2

ER -

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this